Bionano Genomics, Inc. Common Stock (BNGO) is a publicly traded Healthcare sector company. As of May 21, 2026, BNGO trades at $1.23 with a market cap of $12.87M and a P/E ratio of -0.28. BNGO moved +5.13% today. Year to date, BNGO is -22.01%; over the trailing twelve months it is -67.11%. Its 52-week range spans $1.06 to $30.52. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces BNGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bionano Genomics, Inc. Common Stock (BNGO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BNGO moved +5.13% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.23 |
| Market Cap | $12.87M |
| P/E Ratio | -0.28 |
| EPS | $-4.37 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.52 |
| 52-Week Low | $1.06 |
| Volume | 98 |
| Avg Volume | 0 |
| Revenue (TTM) | $28.74M |
| Net Income | $-31.60M |
| Gross Margin | 46.97% |
2 analysts cover BNGO: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.